Point72 Hong Kong’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RRAM
RA
Point72 Hong Kong's HAE Position: Q2 2025 in Review
Point72 Hong Kong sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 5,505 shares — an estimated $350K sold.
Point72 Hong Kong first reported a position in HAE in Q3 2016 and held it in 13 quarters. The position peaked at $959K in Q2 2024. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.
- Point72 Hong Kong reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
- Point72 Hong Kong sold 5,505 Haemonetics shares in Q2 2025, an estimated $350K.
- Point72 Hong Kong first reported a position in Haemonetics in Q3 2016 and held it in 13 quarters.
- Point72 Hong Kong's Haemonetics position peaked at $959K in Q2 2024.
- 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.
Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.